Connection

DAVID GRAHAM to Placebos

This is a "connection" page, showing publications DAVID GRAHAM has written about Placebos.
Connection Strength

0.230
  1. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis. 2014 Apr 01; 209(7):1016-22.
    View in: PubMed
    Score: 0.101
  2. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci. 1983 Jun; 28(6):559-63.
    View in: PubMed
    Score: 0.049
  3. Serological Correlates of Protection against a GII.4 Norovirus. Clin Vaccine Immunol. 2015 Aug; 22(8):923-9.
    View in: PubMed
    Score: 0.028
  4. Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. J Infect Dis. 2014 May 01; 209(9):1452-8.
    View in: PubMed
    Score: 0.025
  5. Healing of benign gastric ulcer: comparison of cimetidine and placebo in the United States. Ann Intern Med. 1985 May; 102(5):573-6.
    View in: PubMed
    Score: 0.014
  6. Why do apparently healthy people use antacid tablets? Am J Gastroenterol. 1983 May; 78(5):257-60.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.